Los Angeles, CA -- (SBWIRE) -- 02/02/2019 -- Global Insulin Pen Needles market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player's various strategies to sustain in the global market. The Insulin Pen Needles report covers the five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data. Apart from this, the Insulin Pen Needles report also covers detail information about various clients which is the most significant element for the manufacturers.
Insulin Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. An insulin pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens. Pen needles come in a variety of needle lengths and diameters and are used by both health professionals and patients for injection of a variety of medications. They are commonly used by people with diabetes who often require multiple daily insulin injections.
The global average price of Insulin Pen Needles is in the decreasing trend, from 121.7 USD/K Unit in 2012 to 118.0 USD/K Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of Insulin Pen Needles includes Standard Insulin Pen Needles and Safety Insulin Pen Needles, and the proportion of Standard Insulin Pen Needles in 2016 is about 95%, and the proportion is in decreasing trend from 2012 to 2016.
Insulin Pen Needles is widely used for Home and Medical Institutions. The most proportion of Insulin Pen Needles is for home use, and the proportion in 2016 is about 92%.
North America is the largest supplier of Insulin Pen Needles, with a production market share nearly 43.5% in 2016. Europe is the second largest supplier of Insulin Pen Needles Media, enjoying production market share nearly 38.7% in 2016.
Get PDF report template at https://www.qyresearch.com/sample-form/form/949283/global-insulin-pen-needles-trends-and-forecast
Europe is the largest consumption place, with a consumption market share nearly 41% in 2016. Following Europe, North America is the second largest consumption place with the consumer market share of 30%.
Market competition is not intense. BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Insulin Pen Needles market is valued at 1530 million US$ in 2018 is expected to reach 2220 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2019-2025.
The following manufacturers are covered:
BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed
Owen Mumford
HTL-Strefa
Beipu
Kangdelai
Ulticare
Allison Medical
Dongbao
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Standard Insulin Pen Needles
Safety Insulin Pen Needles
Segment by Application
Home Use
Medical Institutions
Others
Get Complete Report in your Inbox within 24 hours at https://www.qyresearch.com/index/detail/949283/global-insulin-pen-needles-trends-and-forecast
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.